MSD Korea opposesfinasteride lawsuit
Published: 2004-03-19 07:00:00
Updated: 2004-03-19 07:00:00
Merck & Co's Korean subsidiary, MSD Korea, says it opposed the recent ruling of Seoul District Court to reject the injunction case of finasteride brought against Choong-wae Pharm, and appealed the case to Seoul High Court.
MSD Korea contended that the court's ruling was made on the ground that...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
